Copyright
©The Author(s) 2025.
World J Exp Med. Sep 20, 2025; 15(3): 107711
Published online Sep 20, 2025. doi: 10.5493/wjem.v15.i3.107711
Published online Sep 20, 2025. doi: 10.5493/wjem.v15.i3.107711
Table 3 Diagnostic accuracy of the assessed markers for the epithelial ovarian cancer patients
Test variables | Area under the receiver operating characteristic curve | Cutoff value | Sensitivity | Specificity | P value |
CA125 | 0.943 | 41.1 | 90% | 100% | < 0.001 |
HE4 | 0.936 | 66.4 | 82% | 93.3% | < 0.001 |
Insulin-like growth factors-binding proteins 2 | 0.981 | 553.1 | 98% | 100% | < 0.001 |
TSP1 | 0.653 | 2460 | 70% | 66.7% | 0.046 |
SPP1 | 0.908 | 8.64 | 86.7% | 100% | < 0.001 |
TSP1 + SPP1 | 0.968 | - | 93.3% | 100% | < 0.001 |
CA125 + SPP1 | 0.968 | - | 93.3% | 100% | < 0.001 |
CA125 + HE4 | 0.962 | - | 91.7% | 93.3% | < 0.001 |
CA125 + TSP1 | 0.949 | - | 95% | 83.3% | < 0.001 |
- Citation: Ibrahim NH, Abdellateif MS, Serag DS, Laymouna A, Elaguizy MS, Halim RMA. Clinical significance of differential plasma proteins levels in the diagnosis of epithelial ovarian cancer. World J Exp Med 2025; 15(3): 107711
- URL: https://www.wjgnet.com/2220-315X/full/v15/i3/107711.htm
- DOI: https://dx.doi.org/10.5493/wjem.v15.i3.107711